PharmaPrint Inc.
- Share via
The Irvine maker of dietary supplements and pharmaceuticals from natural plant extracts reported a net loss of $3.3 million, or 24 cents a share, for the first fiscal quarter, compared with a net loss of $4.4 million, or 32 cents a share, for the year-earlier period. Revenue for the quarter ended June 30 rose to $5.4 million from $225,956.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
